BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27377459)

  • 1. A mini-review of chemical and biological properties of polysaccharides from Momordica charantia.
    Zhang F; Lin L; Xie J
    Int J Biol Macromol; 2016 Nov; 92():246-253. PubMed ID: 27377459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Momordica charantia: Functional Components and Biological Activities.
    Jia S; Shen M; Zhang F; Xie J
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29182587
    [No Abstract]   [Full Text] [Related]  

  • 3. Extraction, structures, biological effects and potential mechanisms of Momordica charantia polysaccharides: A review.
    Hu Z; Luo Y; Wu Y; Qin D; Yang F; Luo F; Lin Q
    Int J Biol Macromol; 2024 May; 268(Pt 1):131498. PubMed ID: 38614167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects and associated mechanisms of
    Wang S; Liu Q; Zeng T; Zhan J; Zhao H; Ho CT; Xiao Y; Li S
    Food Funct; 2022 Nov; 13(23):11986-11998. PubMed ID: 36350105
    [No Abstract]   [Full Text] [Related]  

  • 5. Antioxidant activity of Momordica charantia polysaccharide and its derivatives.
    Chen F; Huang G; Yang Z; Hou Y
    Int J Biol Macromol; 2019 Oct; 138():673-680. PubMed ID: 31344411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review.
    Bora AFM; Kouame KJE; Li X; Liu L; Pan Y
    Int J Biol Macromol; 2023 Mar; 231():123173. PubMed ID: 36642359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, physicochemical characteristics, and in vitro biological activities of polysaccharides obtained from fresh bitter gourd (Momordica charantia L.) via room temperature extraction techniques.
    Yan JK; Yu YB; Wang C; Cai WD; Wu LX; Yang Y; Zhang HN
    Food Chem; 2021 Feb; 337():127798. PubMed ID: 32799166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
    Gao H; Wen JJ; Hu JL; Nie QX; Chen HH; Xiong T; Nie SP; Xie MY
    Carbohydr Polym; 2018 Dec; 201():624-633. PubMed ID: 30241862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, analysis, antioxidant activities in vivo of phosphorylated polysaccharide from Momordica charantia.
    Chen F; Huang G; Huang H
    Carbohydr Polym; 2021 Jan; 252():117179. PubMed ID: 33183626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive polysaccharides from
    Zheng J; Shang M; Dai G; Dong J; Wang Y; Duan B
    Crit Rev Food Sci Nutr; 2023 Aug; ():1-24. PubMed ID: 37599638
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological activities and potential health benefit effects of polysaccharides isolated from Lycium barbarum L.
    Jin M; Huang Q; Zhao K; Shang P
    Int J Biol Macromol; 2013 Mar; 54():16-23. PubMed ID: 23200976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun N-terminal kinase 3 signaling pathway.
    Gong J; Sun F; Li Y; Zhou X; Duan Z; Duan F; Zhao L; Chen H; Qi S; Shen J
    Neuropharmacology; 2015 Apr; 91():123-34. PubMed ID: 25510970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactives of
    Xu B; Li Z; Zeng T; Zhan J; Wang S; Ho CT; Li S
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408574
    [No Abstract]   [Full Text] [Related]  

  • 14. Polysaccharide with antioxidant, α-amylase inhibitory and ACE inhibitory activities from Momordica charantia.
    Tan HF; Gan CY
    Int J Biol Macromol; 2016 Apr; 85():487-96. PubMed ID: 26778156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-tumour activities of sulphated polysaccharide obtained from Momordica charantia.
    Guan L
    Nat Prod Res; 2012; 26(14):1303-9. PubMed ID: 22077268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
    Wang Q; Wu X; Shi F; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
    Raish M; Ahmad A; Jan BL; Alkharfy KM; Ansari MA; Mohsin K; Jenoobi FA; Al-Mohizea A
    Int J Biol Macromol; 2016 Oct; 91():394-9. PubMed ID: 27238589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction methods, multiple biological activities, and related mechanisms of Momordica charantia polysaccharide: A review.
    Liu J; Guo Y; Sun J; Lei Y; Guo M; Wang L
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130473. PubMed ID: 38423437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.
    Zhang C; Huang M; Hong R; Chen H
    Int J Biol Macromol; 2019 Feb; 122():619-627. PubMed ID: 30391593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory activity and partial characterisation of polysaccharides from Momordica charantia.
    Deng YY; Yi Y; Zhang LF; Zhang RF; Zhang Y; Wei ZC; Tang XJ; Zhang MW
    Molecules; 2014 Aug; 19(9):13432-47. PubMed ID: 25178064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.